24/7 life science manufacturing IT service launches
Faster GMP incident response and resolution times when manufacturing IT applications fail or are not running to their optimum capacity.
Zenith Technologies has launched and rolled out a global 24/7 manufacturing IT support service specially designed to meet the needs of the life science industry.
Sitting as part of Zenith’s services division, the manufacturing IT team provides high-quality multi-platform engineering support across automation, manufacturing execution systems (MES), digital and lab IT systems.
It offers a single point of contact with faster GMP incident response and resolution times when manufacturing IT applications fail or are not running to their optimum capacity.
David Staunton, director global services at Zenith Technologies, states: “The continuing demand for automation, MES and digital solutions in the life science industry is creating an urgent need for specialist manufacturing IT support. Zenith is perfectly positioned to deliver this as the business has a deep understanding of GMP manufacturing systems and their support applications.
“There’s a strong business case for outsourcing this support as it opens up a depth of knowledge that can’t be achieved alone. For example, if you have one syringe filling machine on your site, your machine’s vendor may have 300 across the market, possessing a level of knowledge that no single customer could achieve alone.
“A close alliance with your vendor, therefore, makes perfect sense to facilitate faster GMP response times, high-quality root cause analysis and reduction of repeating incidents. Zenith works with the leading life science companies globally and has unrivalled knowledge across multiple platforms.
“Having a single point of contact for all applications is also a real advantage to our customers, who get access to the Zenith global resource hub for incident resolution and business improvement strategies.”
The service is designed for life science manufacturers and can be offered onsite, remotely or a combined approach to suit the customer shift support needs. It provides analytical support directly to the end customer, with queries routed to a hub of specialist engineers when required.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.